Clinical Trial Update: BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer

View source ↗

Summary

The document describes BASE HSP110 as a potential therapeutic target and a prognostic marker for microsatellite instability–high colorectal cancer, with relevan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Rectum Cancer, Cancer of Colon | Status: UNKNOWN